Anal Cancer Market Overview
Market Research Future (MRFR) has launched a new release on the global anal cancer market. The report delivers a thorough understanding of the market’s present status and likely future growth trajectory over the forecast period on the basis of the market’s historical growth trajectory and figures. The leading drivers and restraints operating on the global anal cancer market are also profiled in the report to illustrate the extent of their impact on the market.
Get customized Sample with complete Toc, Inclusive of COVID-19 Industry Analysis @ https://www.marketresearchfuture.com/sample_request/1530
Anal cancer is cancer of the anus or the surrounding area. Anal cancer can be caused by all of the regular causes of cancer, i.e. smoking, chewing tobacco, radiation poisoning, etc., but can also be caused by the HPV virus. In fact, HPV accounts for more than 90% of all anal cancers, making it a closely associated pathogen. Anal cancer is rarely found in younger demographics, with people above 60 being the prime candidate for the disease. It is estimated to cause more than 8,000 new cases in the U.S. in 2019, accompanied by more than a thousand deaths. The five-year survival rate for anal cancer is 66%, a considerable improvement upon some other types of cancer but worrying nevertheless.
The global anal cancer market is driven mainly by the growing research efforts being taken to find a cure for cancer and eliminate the disease. Growing government support for the same is likely to be a major driver for the anal cancer market over the forecast period. On the other hand, embarrassment about tackling issues regarding the anus often holds back patients from visiting the physician at an earlier stage. This is likely to be a major restraint on the global anal cancer market over the forecast period, as later diagnosis significantly reduces the chances of survival.
Anal Cancer Market Segmentation:
Global anal cancer market has been segmented on the basis of type into squamous cell carcinoma, adenocarcinoma, perianal skin cancer, melanoma, and others.
On the basis of treatment, the global anal cancer market is segmented into chemotherapy, radio therapy, surgery, and others.
On the basis of end user, the global anal cancer market is segmented into hospitals, clinics, research institutes, and others.
Anal Cancer Market Regional Analysis:
The global anal cancer market is segmented into the Americas, Europe, Asia Pacific, and the Middle East and Africa on the basis of region. The Americas is expected to remain the leading regional market for anal cancer in the coming years due to the growing prevalence of anal cancer in North America and the availability of advanced treatment facilities. The growing prevalence of sexually transmitted HPV in North America is also likely to be a major driver for the anal cancer market in the region over the forecast period. The strong presence of a capable cancer research sector is also likely to be a major driver for the anal cancer market in North America, leading to steady growth of the market over the forecast period. The widespread prevalence of unhealthy dietary patterns such as an excessive consumption of junk food is also likely to be a major driver for the anal cancer market in North America over the forecast period.
Europe is also a major regional market for anal cancer and is likely to retain its position in the global market over the forecast period due to the growing prevalence of anal cancer and the increasing efforts being taken to tackle the problem. Cancer research is highly advanced in Europe, particularly in Western European economies such as France, Germany, and the UK, which bodes well for the anal cancer market in Europe. The increasing aging population in Europe could also emerge as a major driver for the anal cancer market over the forecast period.
Anal Cancer Market Competitive Analysis:
Leading players in the global anal cancer market include Advaxis Inc., Genticel, Taiwan Liposome Company, and ORYX.
Anal Cancer Industry Updates:
In February 2019, researchers found that completing the HPV vaccination timetable on time helps in warding off anal cancer. Most children were receiving the last few shots in the course later than the intended date, increasing their chances of contracting HPV and thus anal cancer.
Get Premium Research Report, Inclusive of COVID-19 Impact Analysis, Find more information @ https://www.marketresearchfuture.com/reports/anal-cancer-market-1530
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
NOTE: Our team of researchers are studying Covid-19 and its impact on various industry verticals and wherever required we will be considering covid-19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.